Trade Summary

4 days ago, Peetz Christopher, serving as CHIEF EXECUTIVE OFFICER at Mirum Pharmaceuticals, Inc. (MIRM), sold 20,000 shares at $122.27 per share, for a total transaction value of $2,445,382.04. Following this transaction, Peetz Christopher now holds 194,309 shares of MIRM.

This sale represents a 9.33% decrease in Peetz Christopher's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, July 6, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, July 8, 2026 at 5:12 PM ET, 2 days after the trade was made.

Mirum Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.